Skip to main content

Table 7 KDQOL scale values among patients who returned a baseline assessment and at least one follow-up assessment

From: Impact of superimposed nephrological care to guidelines-directed management by primary care physicians of patients with stable chronic kidney disease: a randomized controlled trial

KDQOL scaleTimeCombined management (N = 62)PCP management only (N = 60)p
  nValuenValue 
SymptomsT06270.0 (19.8)6070.6 (18.9)0.87
T16174.4 (16.7)5770.4 (19.0)0.22
T25072.7 (17.7)4972.2 (20.0)0.90
Effects of kidney diseaseT05979.5 (21.7)5676.5 (19.4)0.45
T15981.4 (18.4)5175.7 (24.4)0.17
T24880.0 (18.8)4780.9 (19.4)0.82
Burden of kidney diseaseT05970.8 (30.1)6063.2 (28.7)0.16
T16070.3 (31.1)5774.3 (28.3)0.48
T25068.2 (29.5)4770.2 (30.5)0.74
Work statusT06131.1 (31.8)5728.9 (34.0)0.72
T15828.4 (32.6)5325.5 (32.0)0.63
T24927.6 (33.9)4826.0 (32.6)0.82
Cognitive functionT06179.3 (24.2)6075.8 (22.5)0.41
T16076.2 (23.3)5675.7 (22.0)0.92
T25076.8 (23.6)4677.0 (23.9)0.97
Quality of social interactionT06278.3 (18.1)6080.6 (18.2)0.49
T16178.0 (17.5)5778.1 (18.2)0.98
T25078.7 (18.7)4879.8 (16.6)0.75
Sexual functionT02554.5 (39.5)2362.5 (36.0)0.47
T12662.5 (37.9)2068.1 (39.6)0.63
T21866.7 (37.4)1370.2 (40.0)0.80
  1. Continuous variables are expressed as mean (SD)
  2. T0, T1 and T2 represent baseline and follow-up at one and two years respectively